Çoklu Renk Antikorlar
Multicolor Reagents
Immunostep has long been working to find and develop the best antibodies for Flow Cytometry. This has allowed us to obtain monoclonal antibodies that afford a better fluorescence intensity than other products available on the market.
Moreover, Immunostep subjects all its antibodies to stringent testing such as repeatability, diagnostic sensitivity, analytical sensitivity or linearity, specificity and titre, thereby guaranteeing that all its products are suitable for diagnosis and research.
Name | Format | Species Reactivity | Size | Clone | Status Regulatory |
CD15/CD34 | FITC, PE | Human | 50 test | MCS-1, 581 | RUO |
CD16/CD56 | FITC/ PE | Human | 50 test | 3G8, B-A19 | RUO |
CD3 FITC / CD16 + CD56 PE /CD45 PECy5… | FITC, PE, PE-Cyanine5, APC | Human | 50 test | 33-2A3, 3G8+B-A19, IMMU19.2, A3-B1 | RUO |
CD3 FITC / CD8 PE / CD45 PECy5 /CD4 APC | FITC, PE, PE-Cyanine5, APC | Human | 50 test | 33-2A3, 143-44, IMMU19.2, SK3 | RUO |
CD3/CD16+CD56 | FITC/ PE | Human | 50 test | 33-2A3, 3G8, B-A19 | RUO |
CD3/CD19 | FITC/ PE | Human | 50 test | 33-2A3, A3-B1 | IVD-CE |
CD3/CD19/CD45 | FITC, PE, PerCP | Human | 50 test | 33-2A3, A3-B1, D3/9 | RUO |
CD3/CD4 | FITC/ PE | Human | 50 test | 33-2A3, HP2/6, | IVD-CE |
CD3/CD4/CD45 | FITC/ PE/ PE-Cyanine5 | Human | 50 test | 33-2A3, HP2/6, IMMU19.2 | RUO |
CD3/CD8 | FITC/ PE | Human | 50 test | 33-2A3, 143-44 | IVD-CE |
CD3/CD8/CD45 | FITC/ PE/ PerCP | Human | 50 test | 33-2A3, 143-44, D3/9 | RUO |
CD4/CD45RA | FITC/ PE | Human | 50 test | HP2/6, HI100 | RUO |
CD4/CD8 | FITC/ PE | Human | 50 test | HP2/6, 143-44 | IVD-CE |
CD4/CD8/CD3 | FITC/ PE /PECyanine5 | Human | 50 test | HP2/6; 143-44; UCHT-1 | RUO |
CD4/CD8/CD3 | FITC/ PE/ PerCP | Human | 50 test | HP2/6, 143-44, 33-2A3 | RUO |
CD45/CD14 | FITC/ PE | Human | 50 test | D3/9, 47-3D6 | RUO |
CD45RA/CD4 | FITC/ PE | Human | 50 test | HI100, HP2/6 | RUO |
CD5/CD19 | FITC/ PE | Human | 50 test | L17F12, A3-B1 | RUO |
CD5/CD20 | FITC/ PE | Human | 50 test | L17F12, LT20 | RUO |
CD8/CD38 | FITC/ PE | Human | 50 test | 143-44, GR7A4 | RUO |
CD8/CD4 | FITC/ PE | Human | 50 test | 143-44, HP2/6 | RUO |
CD8/CD56 | FITC/ PE | Human | 50 test | 143-44, B-A19 | RUO |
HLA-DR/CD3 | FITC/ PE | Human | 50 test | GRB-1; 33-2A3 | RUO |
HLA-DR/CD8 | FITC/ PE | Human | 50 test | GRB-1, 33-2A3 | RUO |
KAPPA/ CD19 | FITC/ PE | Human | 50 test | NaM76-5F3, A3-B1 | RUO |
KAPPA/ LAMBDA | FITC/ PE | Human | 50 test | NaM76-5F3, Higλ | RUO |
KAPPA/LAMBDA | FITC/ PE | Human | 50 test | Polyclonal Fab2 | RUO |
KAPPA/LAMBDA/CD19 | FITC/ PE/ PE-Cyanine5 | Human | 50 test | polyclonal/polyclonal/HIB19 | RUO |
Lambda/CD19 | FITC/ PE | Human | 50 test | Higλ, A3-B1 | RUO |
MPO/CD22 | FITC/ PE | Human | 50 test | MPO-1/1.7,17, HIB22 | RUO |